71 results
F-1
EX-10.4
OBSVF
ObsEva SA
30 Dec 16
Registration statement (foreign)
12:00am
corresponding to the incidental expenses s is the lessor’s responsibility.
Art. 7
Annual account
Subject to the lump-sum payment, the lessor draws up an annual … -conditioning installations (duration, temperature, cost sharing method, etc.), if these exist, is the lessor’s responsibility. The lessor ensures
DRS
EX-10
OBSVF
ObsEva SA
14 Oct 16
Draft registration statement
12:00am
corresponding to the incidental expenses s is the lessor’s responsibility.
Art. 7
Annual account
Subject to the lump-sum payment, the lessor draws up an annual … -conditioning installations (duration, temperature, cost sharing method, etc.), if these exist, is the lessor’s responsibility. The lessor ensures
F-1
EX-10.3
OBSVF
ObsEva SA
30 Dec 16
Registration statement (foreign)
12:00am
certain activities for research and development of KLH-2109 at its own cost and responsibility before the execution of this Agreement; and
WHEREAS … responsibility for final decision.
The JDC shall meet formally at least semi-annually, or with such other frequency, and at such time and location
6-K
EX-99.2
OBSVF
ObsEva SA
22 Nov 21
Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix
6:05am
. She built the rare diseases business unit with responsibility for commercialization of in-line and launch brands including direction of marketing … was Vice President and US Head of Novartis’ Neuroscience Franchise with responsibility for commercial marketing, sales and operations, and had
DRS
EX-10
82nkp
14 Oct 16
Draft registration statement
12:00am
6-K
EX-99.1
5lyzenpnv93vbz
6 Apr 20
ObsEva SA Announces New Interim Chief Financial Officer
4:00pm
F-3
EX-4.6
03me3d6zmqtjri0u5
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.5
a02m6gd35b5pz ei
7 Aug 19
Shelf registration (foreign)
8:24am
6-K
nslkq3vvs7to0 i7o2
5 Jul 19
Current report (foreign)
6:01pm
F-1
EX-10.2
fkznw ffqjph66mzwvt9
30 Dec 16
Registration statement (foreign)
12:00am
6-K
EX-5.2
mqmu192t 199bjmr
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
DRS
EX-10
90ssac642wecv 5ntp
14 Oct 16
Draft registration statement
12:00am
DRS
EX-10
ew4g11narineard2x
14 Oct 16
Draft registration statement
12:00am
F-3
EX-5.2
cum96stvsbtvi
9 Dec 22
Shelf registration (foreign)
7:06am
F-1
EX-10.1
ntuyxj8vbqhk4tuq ffa
30 Dec 16
Registration statement (foreign)
12:00am
F-3
EX-5.2
frwsah9gyc
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.2
gexxne27og
9 Dec 22
Shelf registration (foreign)
7:06am